Literature DB >> 33911890

Assessment for the Correlation Between Diabetic Retinopathy and Metabolic Syndrome: A Cross-Sectional Study.

Qing Sun1,2, Liang Tang2, Qiurong Zeng2, Mingjun Gu2.   

Abstract

PURPOSE: In this study, we explored the correlation between diabetic retinopathy (DR) and metabolic syndrome (MetS) among diabetes mellitus (DM) patients.
METHODS: Logistic regression analysis was utilized to test the effects of MetS and its indicators on the incidence of DR and vision-related functional burden. The spline smoothing functions of continuous indicators of MetS were used to establish the logistic generalized additive model (GAM). The effective degree of freedom (EDF) =1 was served as a sign of linear relationship. EDF>1 was a sign of a more complex association between MetS and DR.
RESULTS: The proportion of difficulties of looking for objects on the crowded shelves in the DR group was higher than that in the non-DR group (19.40 vs 12.10, P<0.05). Elevated fasting glucose (Glu) and blood pressure levels were related to the vision-related functional burden. The risk of DR development increased by 6% [95% confidence interval (CI): 1.03-1.09, P<0.001] and 1% (95% CI: 1.01-1.02, P=0.004) per 1 unit increase in Glu and systolic blood pressure (SBP) of DM patients, respectively. In the univariate GAM, Glu had a linear effect on DR (EDF=1, P<0.001) with a positive correlation after controlling SBP. And there was a nonlinear correlation between SBP and DR after controlling Glu (EDF=2.44, P=0.024).
CONCLUSION: Both Glu and blood pressure were associated with the occurrence of DR and vision-related functional burden. Controlling the levels of Glu and blood pressure may reduce the risk of DR and vision loss among DM patients.
© 2021 Sun et al.

Entities:  

Keywords:  blood pressure; diabetic retinopathy; generalized additive model; glucose

Year:  2021        PMID: 33911890      PMCID: PMC8075313          DOI: 10.2147/DMSO.S265214

Source DB:  PubMed          Journal:  Diabetes Metab Syndr Obes        ISSN: 1178-7007            Impact factor:   3.168


  32 in total

1.  The metabolic syndrome, insulin resistance, and cardiovascular risk in diabetic and nondiabetic patients.

Authors:  Christoph H Saely; Stefan Aczel; Thomas Marte; Peter Langer; Guenter Hoefle; Heinz Drexel
Journal:  J Clin Endocrinol Metab       Date:  2005-08-09       Impact factor: 5.958

2.  Determination of diabetic retinopathy prevalence and associated risk factors in Chinese diabetic and pre-diabetic subjects: Shanghai diabetic complications study.

Authors:  Can Pang; Lili Jia; Sunfang Jiang; Wei Liu; Xuhong Hou; Yuhua Zuo; Huilin Gu; Yuqian Bao; Qiang Wu; Kunsan Xiang; Xin Gao; Weiping Jia
Journal:  Diabetes Metab Res Rev       Date:  2012-03       Impact factor: 4.876

3.  Association between glucose variability as assessed by continuous glucose monitoring (CGM) and diabetic retinopathy in type 1 and type 2 diabetes.

Authors:  Giovanni Sartore; Nino Cristiano Chilelli; Silvia Burlina; Annunziata Lapolla
Journal:  Acta Diabetol       Date:  2013-02-16       Impact factor: 4.280

Review 4.  Diabetic retinopathy: Early diagnosis and effective treatment.

Authors:  Aris N Kollias; Michael W Ulbig
Journal:  Dtsch Arztebl Int       Date:  2010-02-05       Impact factor: 5.594

5.  Telemedicine for screening diabetic retinopathy: The NO BLIND Italian multicenter study.

Authors:  Ferdinando Carlo Sasso; Pia Clara Pafundi; Aldo Gelso; Valeria Bono; Ciro Costagliola; Raffaele Marfella; Celestino Sardu; Luca Rinaldi; Raffaele Galiero; Carlo Acierno; Chiara de Sio; Luigi Elio Adinolfi
Journal:  Diabetes Metab Res Rev       Date:  2019-01-07       Impact factor: 4.876

Review 6.  Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales.

Authors:  C P Wilkinson; Frederick L Ferris; Ronald E Klein; Paul P Lee; Carl David Agardh; Matthew Davis; Diana Dills; Anselm Kampik; R Pararajasegaram; Juan T Verdaguer
Journal:  Ophthalmology       Date:  2003-09       Impact factor: 12.079

7.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

Authors:  Sarah Wild; Gojka Roglic; Anders Green; Richard Sicree; Hilary King
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

Review 8.  Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials.

Authors:  Rémy Boussageon; Theodora Bejan-Angoulvant; Mitra Saadatian-Elahi; Sandrine Lafont; Claire Bergeonneau; Behrouz Kassaï; Sylvie Erpeldinger; James M Wright; François Gueyffier; Catherine Cornu
Journal:  BMJ       Date:  2011-07-26

9.  Associations of the metabolic syndrome and its components with cognitive impairment in older adults.

Authors:  Insa Feinkohl; Jürgen Janke; Daniel Hadzidiakos; Arjen Slooter; Georg Winterer; Claudia Spies; Tobias Pischon
Journal:  BMC Geriatr       Date:  2019-03-07       Impact factor: 3.921

10.  Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.

Authors:  C R L Cardoso; N C Leite; C B M Moram; G F Salles
Journal:  Cardiovasc Diabetol       Date:  2018-02-24       Impact factor: 9.951

View more
  1 in total

1.  A New Way of Investigating the Relationship Between Fasting Blood Sugar Level and Drinking Glucose Solution.

Authors:  Muhammad Aslam; Mohammed Albassam
Journal:  Front Nutr       Date:  2022-05-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.